Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Rankning i aktier #17188
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Aktiekurs
$2.17
Marknadsvärde
$249.58M
Förändring (1 dag)
-1.67%
Förändring (1 år)
96.34%
Land
CA
Handel Cardiol Therapeutics Inc. (CRDL)

Kategori

Historik för aktiesplit för Cardiol Therapeutics Inc. (CRDL)
Aktien Cardiol Therapeutics Inc. (symbol: CRDL) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Sep 02, 2026.
En CRDL-aktie köpt före Sep 02, 2026 motsvarar nu 0 CRDL-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter